- Home
- EVN vs CVRX Comparison
EVN vs CVRX Comparison
Compare EVN & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- CVRX
- Stock Information
- Founded
- EVN 1998
- CVRX 2000
- Country
- EVN United States
- CVRX United States
- Employees
- EVN N/A
- CVRX N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EVN Finance
- CVRX Health Care
- Exchange
- EVN Nasdaq
- CVRX Nasdaq
- Market Cap
- EVN 418.1M
- CVRX 419.8M
- IPO Year
- EVN N/A
- CVRX 2021
- Fundamental
- Price
- EVN $10.72
- CVRX $13.85
- Analyst Decision
- EVN
- CVRX Strong Buy
- Analyst Count
- EVN 0
- CVRX 7
- Target Price
- EVN N/A
- CVRX $17.83
- AVG Volume (30 Days)
- EVN 101.2K
- CVRX 219.8K
- Earning Date
- EVN 01-01-0001
- CVRX 02-04-2025
- Dividend Yield
- EVN 4.78%
- CVRX N/A
- EPS Growth
- EVN N/A
- CVRX N/A
- EPS
- EVN 0.34
- CVRX N/A
- Revenue
- EVN N/A
- CVRX $51,292,000.00
- Revenue This Year
- EVN N/A
- CVRX $27.21
- Revenue Next Year
- EVN N/A
- CVRX $25.87
- P/E Ratio
- EVN $29.94
- CVRX N/A
- Revenue Growth
- EVN N/A
- CVRX 30.53
- 52 Week Low
- EVN $8.64
- CVRX $6.40
- 52 Week High
- EVN $10.45
- CVRX $22.50
- Technical
- Relative Strength Index (RSI)
- EVN 67.75
- CVRX 39.53
- Support Level
- EVN $10.60
- CVRX $14.07
- Resistance Level
- EVN $10.75
- CVRX $15.42
- Average True Range (ATR)
- EVN 0.09
- CVRX 0.88
- MACD
- EVN 0.02
- CVRX -0.23
- Stochastic Oscillator
- EVN 93.48
- CVRX 13.84
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.